Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Nancy J. Brown
Nancy J. Brown is Hugh Jackson Morgan Professor of Medicine and Pharmacology, and Chair and Physician-in-Chief of the Department of Medicine at Vanderbilt University, USA. A graduate of Yale College and Harvard Medical School, USA, Dr Brown studies how drugs that affect the renin-angiotensin-aldosterone, kallikrein-kinin, and eicosanoid systems alter the risk of thrombosis and fibrosis. Dr Brown is an active member of the American Heart Association Council for High Blood Pressure Research and the American Society of Hypertension. Her honors include the American Society of Hypertension Young Scholar Award, American Federation for Clinical Research Outstanding Investigator Award, the Vanderbilt Grant Liddle Award, the E.K. Frey- E. Werle Foundation Promotion Prize, the AHA Harriet Dustan award, membership in the American Society for Clinical Investigation and in the Association of American Physicians. She is also a Fellow of the American Association for the Advancement of Science.
Bradley M. Denker
Bradley M. Denker is Associate Professor of Medicine at Harvard Medical School, Beth Israel Deaconess Medical Center, USA, and Physician at Brigham and Women's Hospital, USA. He is also the Chief of Nephrology at Harvard Medical Vanguard Associates. Dr Denker is a graduate of State University of New York Medical School in Syracuse, USA. He completed his internal medicine residency at the Johns Hopkins Hospital in Baltimore, Maryland, USA. He did a one-year fellowship in hematology at the laboratory of Dr Peter Agre (2003 Nobel Laureate), at Johns Hopkins, USA. Here he identified a protein in kidney and red blood cells that was ultimately shown to be aquaporin-1. He completed his nephrology fellowship at the Brigham and Women's Hospital, in the laboratory of Dr Eva Neer. Here he mapped structural domains of G protein subunits.
Dr Denker maintains a research laboratory in the Renal Division. His interests are signaling pathways regulating epithelial tight junctions and autosomal dominant polycystic kidney disease (ADPKD). Dr Denker has received teaching awards and is the past-President of the Medical Advisory Board for the National Kidney Foundation serving New England. He has authored numerous chapters and textbooks on various aspects of kidney disease. He has a busy outpatient Renal Clinic. He is a co-recipient of an NIH grant to use electronic medical records - to improve recognition and management of chronic kidney disease.